Form 8.3 - Avadel Pharmaceuticals plc
FORM 8.3…
16,000$
0,25%
Echtzeit-Aktienkurs AVADEL PHARM. SPONS.ADR/1
Bid:
Ask:
Nachrichten zur AVADEL PHARM. SPONS.ADR/1 Aktie
Bank of America discloses 1.3% stake in Avadel Pharmaceuticals By Investing.com
Bank of America discloses 1.3% stake in Avadel Pharmaceuticals…
Morgan Stanley discloses trading in Avadel Pharmaceuticals shares By Investing.com
Morgan Stanley discloses trading in Avadel Pharmaceuticals shares…
Citadel Group discloses 1.13% stake in Avadel Pharmaceuticals By Investing.com
Citadel Group discloses 1.13% stake in Avadel Pharmaceuticals…
ANNOUNCEMENT FOR THE PURPOSES OF ARTICLE 17 "MAR" RULES (EU) NO. 596/2014 (INSIDE INFORMATION) AND RULE 2.8 OF THE IRISH TAKEOVER PANEL ACT 1997, TAKEOVER RULES, 2022 (THE “IRISH TAKEOVER RULES”)
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY (IN WHOLE OR IN PART) IN, INTO OR FROM ANY JURISDICTION…
Stocks making the biggest premarket moves: Warner Bros. Discovery, Cidara Therapeutics, Avadel Pharmaceuticals and more
These are some of the stocks posting the largest moves in premarket trading.…
Geode Capital discloses 2.24% stake in Avadel Pharmaceuticals By Investing.com
Geode Capital discloses 2.24% stake in Avadel Pharmaceuticals…
Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc
DJ Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc The Vanguard Group, Inc. (IRSH) Form 8.3 - The…
Bank of America discloses 3% stake in Avadel Pharmaceuticals By Investing.com
Bank of America discloses 3% stake in Avadel Pharmaceuticals…
Avadel Pharmaceuticals plc (AVDL) Q4 2024 Earnings Call Transcript
…
Avadel Pharmaceuticals: Moving To A Speculative Buy
…
Avadel Pharmaceuticals: Patient Attrition Weighs On 2025 Outlook
…
Avadel Pharmaceuticals falls as Q4 revenue misses estimates; shares sink 20% By Investing.com
Avadel Pharmaceuticals falls as Q4 revenue misses estimates; shares sink 20%…
Avadel Pharmaceuticals CFO buys $24,018 in stock By Investing.com
Avadel Pharmaceuticals CFO buys $24,018 in stock…
Avadel Pharmaceuticals to Present at the Jefferies London Healthcare Conference
DUBLIN, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming…
Avadel Pharmaceuticals plc (AVDL) Q3 2024 Earnings Call Transcript
…
Avadel Pharmaceuticals: The Oxybate War With Jazz Waxes On
…
Avadel Pharmaceuticals plc (AVDL) Q2 2024 Earnings Call Transcript
…
Avadel Pharmaceuticals plc 2024 Q2 - Results - Earnings Call Presentation
…
Avadel Pharmaceuticals to Join Russell 3000® Index
DUBLIN, June 27, 2024 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming…
Avadel Pharmaceuticals: Inflection Point Ahead
…
Earnings call: Avadel Pharmaceuticals posts strong Q1 2024 results By Investing.com
Earnings call: Avadel Pharmaceuticals posts strong Q1 2024 results…
Avadel Pharmaceuticals: A Deep Dive Into Lumryzs Once-Nightly Revolution
…
Avadel Pharmaceuticals: Robust Launch Of Lumryz And Eased Litigation Overhang
…
Avadel Pharmaceuticals plc (AVDL) Q4 2023 Earnings Call Transcript
…
Avadel Pharmaceuticals Q4 2023 Earnings Preview
…